Which of the following is a monoclonal antibody against IL-5: (A) Omalizumab, (B) Mepolizumab, (C) Tocilizumab, (D) Alemtuzumab
Answer is B. Mepolizumab & Reslizumab are monoclonal antibodies against IL-5 used in bronchial asthma, which act by inhibiting recruitment of esinophils.